Dow Up 1.23% Nasdaq Up 0.38%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
194.00 Up 3.51(1.84%) 2:27PM EDT - Nasdaq Real Time Price
Prev Close:190.49
Open:190.21
Bid:193.82 x 200
Ask:193.93 x 100
1y Target Est:204.29
Beta:1.07
Earnings Date:Jan 28 - Feb 2 (Est.)
Day's Range:189.16 - 194.07
52wk Range:113.14 - 194.07
Volume:728,659
Avg Vol (3m):1,161,750
Market Cap:38.47B
P/E (ttm):80.70
EPS (ttm):2.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 1.84%38.47B
AMGNUp 1.39%122.59B
BAXDown 0.66%37.89B

Key Statistics

Forward P/E (1 yr):33.09
P/S (ttm):18.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.15
Quarterly EPS Est (Dec-14) :1.26
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback